ATGE vs GSK · P/E 21, rev $1.79B vs P/E 13, $103.31B cap
Adtalem Global Education Inc (ATGE) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Adtalem Global Education Inc (ATGE) is a education & training services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ATGE revenue for 2025-06-30 was $1.79B. Net income was $237.1M. Revenue was up 12.9% from 2024-06-30 to 2025-06-30. ATGE currently screens at market cap $4.42B and trailing P/E 20.8.
GSK does not have a complete income-statement cache yet.
ATGE currently screens at market cap $4.42B and trailing P/E 20.8. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ATGE and GSK stock pages for the full models.
Not investment advice.